Compare Medpace Holdings Inc (MEDP) vs Vital Farms Inc (VITL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Vital Farms Inc — how do they compare? Medpace Holdings Inc trades at $612.05 (market cap $16.82B), while Vital Farms Inc trades at $9.33 (market cap $405.27M). The key difference: Medpace Holdings Inc is far larger — about 41.5× Vital Farms Inc's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Vital Farms Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and Vital Farms Inc for 14 Days on average.
| MEDP | VITL | |
|---|---|---|
Market Cap | $16.82B | $405.27M |
Volume | 223,093 | 1,810,837 |
Sector | Health | Consumer Staples |
52-Week High | $630.19 | $43.40 |
52-Week Low | $393.42 | $8.28 |
Typical Hold Time | 14 Days | 14 Days |
Enterprise Value | $16.44B | $492.28M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medpace (MEDP) trades at $602.70, down slightly by 0.26% on the day, with a neutral technical outlook and bullish moving averages. The company reported strong earnings beats in recent quarters, with Q3 2026 results expected on October 21, 2026. Revenue and net income are projected to grow in 2026, supported by a robust 17.67% net income margin and exceptional ROE of 162.15%. However, valuation ratios like P/E of 35.41 and P/B of 38.77 suggest a premium pricing relative to peers.
The stock offers upside to the consensus price target of $620.44, but risks include high valuation multiples, CEO stock sales, and mixed institutional positioning. Investors should weigh strong profitability against potential overvaluation and monitor Q3 earnings for continued momentum.
Vital Farms (VITL) trades at $9.435, up 2.11% today, amid a challenging period marked by volatile earnings and negative cash flows. The stock exhibits a bearish technical trend with support near $9 and resistance at $10, while fundamentals show revenue stability but collapsing profitability, with net income margin at 0.02% in 2026. Recent news highlights potential strategic options, including a sale, as the company navigates egg pricing pressure.
The outlook is mixed: analyst consensus is bullish with a $13.11 price target, but near-term risks from industry oversupply and weak margins persist. Upside hinges on execution of strategic reviews and margin recovery, while downside exposure includes sustained cash burn and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Vital Farms Inc
Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →
